In particular, Pierson et al. demonstrated that more than 30% of EnOCs carry activating PIK3CA mutations, after analyzing the genetic data from a 26-EnOC cohort, as well as from 96-EnOC cases curated in the Genomics Evidence Neoplasia Information Exchange (GENIE) database [61]. The gene discussed is PIK3CA; the disease is neoplasm.